Hazy Med CBD by Poppa Pains
Sativa-dominant strains
Hazy Med Cbd by Poppa Pains is a primarily sativa-dominant strain developed by Poppa Pain Strains. It is recognized for its balanced cannabinoid and terpene profile, offering therapeutic potential alongside an invigorating experience. This cultivar has gained attention for its unique sensory qualities and its suitability for both medicinal and recreational use.
Appearance
Hazy Med Cbd presents visually striking buds characterized by a dense structure and a frosty coating of trichomes. The coloration is predominantly verdant green, often interspersed with purple hues and orange pistils. Its compact bud formation is indicative of its potent genetic heritage.
Aroma & Flavor
The aroma of Hazy Med Cbd is a complex blend, featuring notes of pine, citrus, and subtle floral undertones. This olfactory profile is complemented by a flavor that mirrors its scent, with a harmonious mix of citrus and earthy notes, often rounded out by a smooth, slightly sweet finish.
Effects
This sativa-dominant strain is known for providing an energetic uplift, promoting focus and creativity. Users report experiencing a sense of calm alongside these stimulating effects, making it suitable for daytime use. Its balanced profile aims to offer therapeutic benefits without significant intoxicating effects.
Terpenes & Cannabinoids
Hazy Med Cbd features a terpene profile rich in pinene, limonene, linalool, and myrcene, contributing to its distinct aroma and flavor. The cannabinoid profile is characterized by low CBD levels (less than 1%) and THC content ranging from 15-25%. This composition is geared towards providing medicinal benefits with a clear-headed experience.
Origins & Lineage
Developed by Poppa Pain Strains, Hazy Med Cbd is the result of meticulous breeding that emphasizes its sativa heritage. The strain incorporates genetics from high-caliber sativas, selected for their therapeutic potential and ability to promote mental clarity. Poppa Pain Strains integrated lessons from award-winning cultivars in its development.